financetom
Business
financetom
/
Business
/
Veon Q2 Earnings, Revenue Rise
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Veon Q2 Earnings, Revenue Rise
Aug 7, 2025 3:16 AM

05:50 AM EDT, 08/07/2025 (MT Newswires) -- Veon ( VEON ) reported Q2 earnings Thursday of $8.30 per diluted American depository share, up from $0.94 a year earlier.

Operating revenue for the quarter ended June 30 was $1.09 billion, up from $1.03 billion a year earlier.

A single analyst surveyed by FactSet expected $1.02 billion.

Veon ( VEON ) shares were up 7% in recent premarket activity.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
AI Meets Real Estate: Janover Launches Advanced Voice Tool For Customer Relationship Management
AI Meets Real Estate: Janover Launches Advanced Voice Tool For Customer Relationship Management
Nov 11, 2024
Janover Inc. ( JNVR ) shares surged premarket on Monday after the company announced the launch of its AI voice tool for CRM operations. The voice tool is currently in internal use and soon to be available for licensing and is designed to transform customer relationship management for the real estate industry. The tool offers streamlined, high-quality interactions via phone,...
Cognyte Software Enters $10 Million Deal With Asia-Pacific Law Enforcement Agency for Border Integrity
Cognyte Software Enters $10 Million Deal With Asia-Pacific Law Enforcement Agency for Border Integrity
Nov 11, 2024
09:20 AM EST, 11/11/2024 (MT Newswires) -- Cognyte Software ( CGNT ) said Monday it has entered into an agreement valued at over $10 million to help support the border integrity efforts of an unnamed law enforcement agency in the Asia-Pacific region. The company said it will provide the customer with expanded investigative analytics capacity to address criminal entry and...
Aptevo Therapeutics' Bispecific Antibody Meets Trial Endpoints
Aptevo Therapeutics' Bispecific Antibody Meets Trial Endpoints
Nov 11, 2024
09:27 AM EST, 11/11/2024 (MT Newswires) -- Aptevo Therapeutics ( APVO ) said Monday that a phase 1 trial of ALG.APV-527 to treat solid tumors has met the trial endpoint of adequate exposure, safety, tolerability and biological activity. The interim results from phase 1 trials of ALG.APV-527 are showing encouraging outcomes, particularly in terms of safety and disease stability in...
Natural Gas Price Jumps on Cooling Forecasts and Lower Production
Natural Gas Price Jumps on Cooling Forecasts and Lower Production
Nov 11, 2024
09:26 AM EST, 11/11/2024 (MT Newswires) -- Natural gas was last seen up 7.5% on expectations cooler weather is on the way to boost heating demand, while production remains light. Gas for December delivery was last seen up US$0.20 to US$2.87 per million British thermal units, the highest since Oct.7. Long-term forecasts from the National Weather Service see much warmer...
Copyright 2023-2026 - www.financetom.com All Rights Reserved